Structure and procedures of the pharmacy and therapeutic committees in Spanish hospitals

Pharmacy World and Science

Volumn 32, Issue 6, 2010, Pages 767-775

  Puigventós, Francesc ^a   Santos Ramos, Bernardo ^b   Ortega, Ana ^c   Durán García, Esther ^d  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Data collection; Decision making; Formularies; Hospital; Organizational; Pharmacy and therapeutics committee; Questionnaires; Spain

Indexed keywords

ARTICLE; CLINICAL DECISION MAKING; CLINICAL EVALUATION; CLINICAL PROTOCOL; CONTROLLED STUDY; HOSPITAL PLANNING; HUMAN; INTERDISCIPLINARY COMMUNICATION; INTERHOSPITAL COOPERATION; JOB PERFORMANCE; ORGANIZATIONAL STRUCTURE; PHARMACY AND THERAPEUTICS COMMITTEE; PRIVATE HOSPITAL; PROFESSIONAL COMPETENCE; PUBLIC HOSPITAL; SPAIN; TREATMENT INDICATION; UNIVERSITY HOSPITAL;

CROSS-SECTIONAL STUDIES; HOSPITALS; HUMANS; PHARMACY AND THERAPEUTICS COMMITTEE; PHARMACY SERVICE, HOSPITAL; PILOT PROJECTS; QUESTIONNAIRES; SPAIN;

EID: 79952698471     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-010-9435-4     Document Type: Article

References (26)

1. Mannebach MA, Ascione FJ, Gaither Ca, Baggozi RP, Cohen IA, Ryan ML. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals. Am J Health-Syst Pharm. 1999;56:622-8. (Pubitemid 29162925)
2. Tyler LS, Cole SW, May JR, Millares M, Valentino MA, Vermeulen LC Jr, et al. ASHP Expert Panel on Formulary Management. ASHP guidelines on the pharmacy and therapeutics committee and the formulary system. Am J Health-Syst Pharm. 2008;65:1272-83. (Pubitemid 351898364)
3. Fijn R, Brouwers JR, Knaap RJ. Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures. Br J Clin Pharmacol. 1999;48:239-46.
4. Pedersen CA, Schneider PJ, Santell JP. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing - 2001. Am J Health-Syst Pharm. 2001;58:2251-66. (Pubitemid 33140903)
5. Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing - 2004. Am J Health-Syst Pharm. 2005;62:378-90. (Pubitemid 40394617)
6. Thurmann PA, Harder S, Steioff A. Structure and activities of hospital drug committees in Germany'. Eur J Clin Pharmacol. 1997;52:429-35. (Pubitemid 27395641)
7. Tan EL, Day RO, Brien JA. Prioritising drug and therapeutics committee (DTC) decisions: a national survey. Pharm World Sci. 2007;29:90-6.
8. Cooke J, Mason AR, Drummond MF, Towse AK. Medication management in English National Health Service hospitals. Am J Health-Syst Pharm. 2005;62:189-95. (Pubitemid 40674550)
9. Willems L, Raymakers A, Sermeus W, Vleugels A, Laekeman G. Survey of hospital pharmacy practice in Flemish-speaking Belgium. Am J Health-Syst Pharm. 2005;62:321-4. (Pubitemid 40403551)
10. Mittmann N, Knowles S. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities. Can J Clin Pharmacol. 2009;16:e171-7.
11. Shalansky SJ, Virk R, Ackman M, Jackevicius C, Kertland H, Tsuyuki R, et al. Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process. Can J Cardiol. 2003;19:173-9. (Pubitemid 36401728)
12. Spanish Ministry of Health and Social Policy. Spanish Government. SNS Primary Care Centres Records and the Nacional Hospital Records (internet database). Madrid. Ministry of Health and Social Policy, 2007. 20 July 2010. Available from: http://www.msps.es/ciudadanos/prestaciones/centrosServiciosSNS/ hospitales/home.htm.
13. Santos B, Flores S, Briones E, Marín R, Gallego S, Bautista FJ. Update of the guide for the introduction of new drugs. Andalusian Agency for Health Technology Assessment, Seville. Reports, studies and research. Edited by the Spanish Ministry of Health and Consumer Affairs. Madrid (Spain), 2007. 20 July 2010. Available from: http://www.juntadeandalucia.es/salud/servicios/ contenidos/nuevaaetsa/up/AETSA-2006-03-GINF.pdf.
14. Marín R, Santos B, Briones E, Flores S, Gallego S, Bautista J. Implementation of the guidelines for the introduction of new drugs (GINF) in Andalusian hospitals. Farm Hosp. 2007;31:212-7.
15. Group for Innovation Assessment, Standardisation and Research in the Selection of Drugs (GENESIS) of the Spanish Association of Hospital Pharmacy. Madre Programme. Procedures Manual. PDF 3.0 version. September 2005. 20 July 2010. Available from: http://genesis.sefh.es/basesmetodologicas/programamadre/ index.html.
16. Walk SU, Bertsche T, Kaltschmidt J, Pruszydlo MG, Hoppe-Tichy T, Walter-Sack I, et al. Rule-based standardised switching of drugs at the interface between primary and tertiary care. Eur J Clin Pharmacol. 2008;64:319-27.
17. Gray T, Bertch K, Galt K, Gonyeau M, Karpiuk E, Oyen L, et al. American College of Clinical Pharmacy. Guidelines for therapeutic interchange-2004. Pharmacotherapy. 2005;11:1666-80.
18. Delgado O, Puigventós F, Llodrá V, Comas F, Cervera M, Sánchez A, et al. Program for the substitution of therapeutic equivalents in the hospital setting. Rev Clin Esp. 2000;200:261-70.
19. Porta B, Borras C, Jimenez NV. Therapeutic interchange standardization for angiotensin II receptor antagonists in the treatment of hypertension in the hospital setting. Farm Hosp. 2005;29:104-12.
20. Peris JF, Faus VJ, de la Vega A, Martines G, Martínez MA. Therapeutic interchange between angiotensin II receptor blockers in institutionalized elderly patients: implementing a protocol. Farm Hosp. 2003;27:290-7. (Pubitemid 37267724)
21. Navarro S, Font I, Lerma E, López E, Martínez MJ, Poveda JL. Therapeutic interchange of drugs not included in the hospitals pharmacotherapeutic guide: a quality programme. Farm Hosp. 2004;28:266-74.
22. Márquez-Peiró JF, Porta-Oltra B, Borrás-Almenar C. Therapeutic exchange of angiotensin II receptor antagonists in patients hospitalised in a thraumatology unit. Farm Hosp. 2009;33:66-71.
23. Crespí M, Delgado O, Ventayol P, Lafuente A, Pinteño M, Escrivá A, et al. A prospective randomized study of sulphonylureas therapeutic interchange in patients with type 2 diabetes mellitus. Farm Hosp. 2004;28:426-32. (Pubitemid 40215025)
24. Alós M, Mangues MA, Santos-Ramos B. Spanish presence in BPS accreditation. Farm Hosp. 2010. doi:10.1016/j.farma.2010.01.003.
25. Fry RN, Avey SG, Sullivan SD. The Academy of Managed Care Pharmacy Format for Formulary Submissions: an evolving standard - a Foundation for Managed Care Pharmacy Task Force report. Value Health. 2003;6:505-21. (Pubitemid 37187712)
26. Australian Government. Department of Health and Ageing. Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee [Internet]. 20 July 2010. Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/ health-pbs-general-pubspharmpac-gusubpac.htm.